Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for a cabozantinib trial in non-small cell lung cancer with brain metastases is displayed instead of an access-denied page. It includes study details and results information, eligibility criteria, and a notice that the trial was terminated due to slow patient accrual.
    Difference
    58%
    Check dated 2026-11-09T13:28:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0 on the error page.
    Difference
    0.2%
    Check dated 2026-11-02T13:26:49.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, saying that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-26T14:44:54.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:23:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:12:59.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details, with an error header visible. This indicates that the study record is currently inaccessible and the content is replaced by an access-denied message.
    Difference
    20%
    Check dated 2026-09-21T14:43:17.000Z thumbnail image

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.